Bisphosphonate safety and efficacy in chronic kidney disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Bisphosphonate safety and efficacy in chronic kidney disease

Published:2012-10 Issue:8 Volume:82 Page:833-835
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Ott Susan M.

Publisher

Elsevier BV

Subject

Nephrology

Reference11 articles.

1. Bisphosphonate nephrotoxicity;Perazella;Kidney Int,2008

2. Renal safety of annual zoledronic acid infusions in osteoporotic postmenopausal women;Boonen;Kidney Int,2008

3. Zoledronic acid in reducing clinical fracture and mortality after hip fracture;Lyles;N Engl J Med,2007

4. Toxic acute tubular necrosis following treatment with zoledronate (Zometa);Markowitz;Kidney Int,2003

5. Biochemical and molecular mechanisms of action of bisphosphonates;Rogers;Bone,2011

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bisphosphonates;BMJ;2024-08-21

2. Get-up and Go: Adynamic Bone Disease in Chronic Kidney Disease Patient;Archives of Pharmacy Practice;2023

3. Zoledronic Acid use and Adverse Drug Reaction (ADR);Research Journal of Pharmacy and Technology;2022-05-30

4. Suppression of bone remodeling associated with long-term bisphosphonate treatment is mediated by microRNA-30a-5p;Bioengineered;2022-04-01

5. Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD);Primer on Nephrology;2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3